Zacks Investment Research lowered shares of Bovie Medical (NYSEAMERICAN:BVX) from a hold rating to a sell rating in a report released on Friday.

According to Zacks, “Bovie Medical Corporation, formerly An-Con Genetics Inc., is engaged in the manufacturing and marketing of a diverse line of medical devices and advanced coating technologies. “

Separately, ValuEngine lowered shares of Bovie Medical from a hold rating to a sell rating in a report on Monday, November 6th.

Bovie Medical (BVX) opened at $2.47 on Friday. The firm has a market cap of $83.53, a price-to-earnings ratio of -15.44 and a beta of -0.77. Bovie Medical has a fifty-two week low of $1.87 and a fifty-two week high of $4.29.

Several hedge funds and other institutional investors have recently bought and sold shares of BVX. Archon Capital Management LLC boosted its holdings in shares of Bovie Medical by 2,841.7% in the 4th quarter. Archon Capital Management LLC now owns 2,208,538 shares of the medical device company’s stock valued at $5,742,000 after buying an additional 2,133,462 shares during the period. RTW Investments LP acquired a new position in shares of Bovie Medical in the 3rd quarter valued at about $3,852,000. Royce & Associates LP acquired a new position in shares of Bovie Medical in the 4th quarter valued at about $1,711,000. Cowen Prime Services LLC boosted its holdings in shares of Bovie Medical by 69.4% in the 4th quarter. Cowen Prime Services LLC now owns 295,041 shares of the medical device company’s stock valued at $767,000 after buying an additional 120,871 shares during the period. Finally, Raymond James Financial Services Advisors Inc. acquired a new position in shares of Bovie Medical in the 2nd quarter valued at about $199,000.

TRADEMARK VIOLATION NOTICE: This report was originally reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this report on another site, it was stolen and republished in violation of U.S. and international copyright and trademark legislation. The original version of this report can be accessed at https://www.thecerbatgem.com/2018/02/10/bovie-medical-bvx-lowered-to-sell-at-zacks-investment-research.html.

About Bovie Medical

Bovie Medical Corporation (Bovie) is an energy-based medical device company. The Company is engaged in the design, development and manufacturing of electrosurgical equipment by producing equipment for medical device manufacturers through original equipment manufacturing (OEM) agreements, as well as start-up companies.

Get a free copy of the Zacks research report on Bovie Medical (BVX)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Bovie Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bovie Medical and related companies with MarketBeat.com's FREE daily email newsletter.